Avidity Partners Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Hold
77,800
1.7% 10
2026
Q1
$9.17M Buy
77,800
+27,500
+55% +$3.84M 1.86% 9
2025
Q4
$8.24M Buy
50,300
+27,000
+116% +$4.23M 2.38% 10
2025
Q3
$3.11M Sell
23,300
-83,200
-78% -$10.1M 0.71% 31
2025
Q2
$13.2M Buy
+106,500
New +$13.6M 2.64% 12

Other funds holding RGEN

Avidity Partners Management's RGEN Position: Q2 2026 in Review

Avidity Partners Management held its Repligen (RGEN) position steady in Q2 2026 at 77,800 shares worth $10.6M. The position accounts for 1.7% of the portfolio, ranked #10.

Avidity Partners Management first reported a position in RGEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $13.2M in Q2 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Avidity Partners Management held 77,800 shares of Repligen worth $10.6M as of Q2 2026.
  • Avidity Partners Management left its Repligen share count unchanged in Q2 2026.
  • Repligen made up 1.7% of Avidity Partners Management's portfolio in Q2 2026, its #10 holding.
  • Avidity Partners Management first reported a position in Repligen in Q2 2025 and has held it in 5 quarters since.
  • Avidity Partners Management's Repligen position peaked at $13.2M in Q2 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Avidity Partners Management's 13F filing for Q2 2026, filed 14 Aug 2026.